The images above are shown for illustration purposes only. They may not be an exact representation of the product.

Semaglutide and Tirzepatide Injectable

Compounded semaglutide and tirzepatide formulations prepared according to prescriber direction. Prescription required.

This medication requires a prescription.

Additional Information

Semaglutide and tirzepatide are GLP-1–based medications that may be prescribed as part of a provider-directed metabolic health plan. HDRx compounds these formulations according to individualized prescriber specifications, including strength and dosage form.

Each preparation is made to order based on a valid prescription. Compounded medications are not FDA-approved and are prepared to meet specific patient needs when commercially available options may not be suitable.

Patients should consult their licensed healthcare provider to determine whether a compounded GLP-1 formulation is appropriate for their individual health goals.

Related Products

The formulas and/or statements listed are provided for educational purposes only. They are compounding ideas that have commonly been requested by physicians, and have not been evaluated by the Food and Drug Administration. Formulas and/or material listed are not to be interpreted as a promise, guarantee or claim of therapeutic efficacy or safety. The information contained herein is not intended to replace or substitute for conventional medical care, or encourage its abandonment. Every patient is unique, and formulas should be adjusted to meet their individual needs.
Search